Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedDec 02, 2024
DataAggregated Company Financials
Companies33
  • 7D4.3%
  • 3M0.4%
  • 1Y24.5%
  • YTD20.2%

PeptiDream is up 7.4%, leading the way for the Biotech industry, which has gained 4.3%. In the same time, Takara Bio was down 5.2%. This takes the industry's 12 month performance to a gain of 25%. Looking forward, earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 03 Dec 2024JP¥1.1tJP¥207.2b-JP¥12,080,899,000.0022.8x-92.5x5.4x
Thu, 31 Oct 2024JP¥1.1tJP¥214.3b-JP¥3,941,502,000.0022.6x-279.5x5.1x
Sat, 28 Sep 2024JP¥1.1tJP¥214.3b-JP¥2,078,229,000.0022x-552.8x5.4x
Mon, 26 Aug 2024JP¥1.0tJP¥210.1b-JP¥580,439,000.0014.2x-1768.1x4.9x
Wed, 24 Jul 2024JP¥1.1tJP¥187.7b-JP¥15,871,901,000.0093.8x-66.7x5.6x
Fri, 21 Jun 2024JP¥904.7bJP¥187.7b-JP¥15,773,284,000.0082.7x-57.4x4.8x
Sun, 19 May 2024JP¥769.6bJP¥194.2b-JP¥14,975,545,000.0093.1x-51.4x4x
Tue, 16 Apr 2024JP¥738.7bJP¥194.2b-JP¥15,746,837,000.0065.1x-46.9x3.8x
Thu, 14 Mar 2024JP¥776.8bJP¥193.6b-JP¥19,603,997,000.0060.1x-39.6x4x
Sat, 10 Feb 2024JP¥747.3bJP¥222.4b-JP¥12,442,827,000.0016.7x-60.1x3.4x
Mon, 08 Jan 2024JP¥802.9bJP¥222.3b-JP¥12,668,455,000.0017.4x-63.4x3.6x
Wed, 06 Dec 2023JP¥779.0bJP¥221.9b-JP¥12,426,487,000.0016.6x-62.7x3.5x
Fri, 03 Nov 2023JP¥746.6bJP¥223.0b-JP¥14,350,085,000.0019.3x-52x3.3x
Sun, 01 Oct 2023JP¥847.8bJP¥223.0b-JP¥14,518,735,000.0026.2x-58.4x3.8x
Tue, 29 Aug 2023JP¥910.1bJP¥225.1b-JP¥19,814,131,000.0049.6x-45.9x4x
Thu, 27 Jul 2023JP¥918.9bJP¥223.7b-JP¥20,836,669,000.0049.1x-44.1x4.1x
Sat, 24 Jun 2023JP¥973.0bJP¥223.2b-JP¥20,139,670,000.0064.6x-48.3x4.4x
Mon, 22 May 2023JP¥915.5bJP¥218.6b-JP¥25,244,669,000.0032.1x-36.3x4.2x
Wed, 19 Apr 2023JP¥959.7bJP¥218.3b-JP¥21,583,522,000.0021.9x-44.5x4.4x
Fri, 17 Mar 2023JP¥902.5bJP¥218.1b-JP¥18,469,580,000.0020.6x-48.9x4.1x
Sun, 12 Feb 2023JP¥957.1bJP¥200.2b-JP¥23,403,917,000.0038.1x-40.9x4.8x
Tue, 10 Jan 2023JP¥907.3bJP¥186.8b-JP¥24,722,604,000.0041.8x-36.7x4.9x
Thu, 08 Dec 2022JP¥897.7bJP¥186.6b-JP¥26,666,433,000.0045.6x-33.7x4.8x
Sat, 05 Nov 2022JP¥813.4bJP¥176.5b-JP¥24,989,270,000.0046.8x-32.5x4.6x
Mon, 03 Oct 2022JP¥852.9bJP¥176.5b-JP¥24,974,270,000.0042.3x-34.2x4.8x
Wed, 31 Aug 2022JP¥950.4bJP¥174.4b-JP¥21,144,270,000.0022x-44.9x5.4x
Fri, 29 Jul 2022JP¥970.6bJP¥171.3b-JP¥16,112,943,000.0020.9x-60.2x5.7x
Sun, 26 Jun 2022JP¥879.1bJP¥171.3b-JP¥16,112,943,000.0020.6x-54.6x5.1x
Tue, 24 May 2022JP¥943.1bJP¥169.3b-JP¥13,349,721,000.0011.8x-70.6x5.6x
Thu, 21 Apr 2022JP¥1.0tJP¥164.2b-JP¥13,043,295,000.0014.7x-78.7x6.3x
Sat, 19 Mar 2022JP¥1.1tJP¥164.2b-JP¥13,044,654,000.0015.2x-82.4x6.5x
Mon, 14 Feb 2022JP¥1.0tJP¥159.8b-JP¥6,977,039,000.0015.2x-149.3x6.5x
Wed, 12 Jan 2022JP¥1.2tJP¥163.5b-JP¥5,447,358,000.0018.2x-218.1x7.3x
Fri, 10 Dec 2021JP¥1.3tJP¥163.7b-JP¥6,105,358,000.0018.5x-206.3x7.7x
Price to Earnings Ratio

-206.3x


Total Market Cap: JP¥1.3tTotal Earnings: -JP¥6,105,358,000.00Total Revenue: JP¥163.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Biotech Industry Price to Earnings3Y Average -136.5x202220232024
Current Industry PE
  • Investors are optimistic on the Japanese Biotechs industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 4.8x is lower than the industry's current PS ratio of 5.4x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 8.2% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market-0.49%
Healthcare1.17%
Biotech4.27%
Biotech4.27%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
2160 GNI GroupJP¥3.32k18.7%
+JP¥26.2b
3.3%PE23.2x
4587 PeptiDreamJP¥2.98k6.2%
+JP¥22.7b
132.7%PE22.6x
219A HeartseedJP¥1.51k3.5%
+JP¥1.1b
n/an/a
4894 CuoripsJP¥5.17k2.6%
+JP¥1.0b
182.4%PS1801.1x
190A Chordia TherapeuticsJP¥259.005.7%
+JP¥947.5m
n/aPB4.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

2160

JP¥3,320.00

GNI Group

7D

18.7%

1Y

3.3%

4894

JP¥5,170.00

Cuorips

7D

2.6%

1Y

182.4%

4587

JP¥2,984.50

PeptiDream

7D

6.2%

1Y

132.7%

4597

JP¥50.00

Solasia Pharma K.K

7D

-5.7%

1Y

-5.7%

4592

JP¥956.00

SanBio

7D

-2.3%

1Y

84.9%

4588

JP¥703.00

Oncolys BioPharma

7D

-3.6%

1Y

15.8%

4564

JP¥31.00

OncoTherapy Science

7D

-6.1%

1Y

34.8%

2929

JP¥984.00

Pharma Foods International

7D

1.4%

1Y

-22.5%

190A

JP¥259.00

Chordia Therapeutics

7D

5.7%

1Y

n/a

7777

JP¥108.00

3-D Matrix

7D

-6.1%

1Y

-36.8%

219A

JP¥1,505.00

Heartseed

7D

3.5%

1Y

n/a

7776

JP¥505.00

CellSeed

7D

-8.5%

1Y

71.8%

4883

JP¥130.00

Modalis Therapeutics

7D

-9.1%

1Y

0.8%

4882

JP¥735.00

Perseus Proteomics

7D

0.7%

1Y

3.1%